ADHD in Women: The Diagnosis Gap That Changed My Life

The Girl Who Was 'Just Lazy'

I was thirty-one when a psychiatrist told me I had ADHD. I had spent twenty-five years being told I was scattered, disorganised, too sensitive, not trying hard enough. I had been called gifted and then disappointing, often in the same school report. I had developed an elaborate architecture of coping mechanisms — alarms, colour-coded notebooks, obsessive lists — that kept me functional but exhausted.

The diagnosis did not feel like a label. It felt like a translation. Suddenly there was a word for the thing that made me different, and more importantly, a body of research explaining why I had been missed.

They did not diagnose me because I was a girl, and girls with ADHD do not look like the textbooks. The textbooks were written about boys.

The Research Gap: Built by Men, for Men

ADHD — Attention Deficit Hyperactivity Disorder — was first formally described in the medical literature in the 1960s and 1970s, primarily through studies of hyperactive boys. The diagnostic criteria in the DSM-5, the standard classification used by clinicians worldwide, were developed from this research. The symptoms that define ADHD — inattention, hyperactivity, impulsivity — were modelled on the presentations most commonly seen in male children.

This is not a minor historical footnote. It has shaped how clinicians identify ADHD for decades. Boys with ADHD tend to present as disruptive: they run around the classroom, interrupt, cannot sit still. Their symptoms are visible, externalised, and impossible to ignore. Girls with ADHD are far more likely to present as inattentive: they daydream, they forget, they lose things, they internalise. Their symptoms are quiet, internal, and easily attributed to other causes — anxiety, depression, hormonal issues, or simply being a girl who does not try hard enough.

The research gap is stark. A 2020 meta-analysis published in the *Journal of Attention Disorders* found that girls with ADHD are diagnosed later, referred for assessment less frequently, and more likely to receive incorrect initial diagnoses. A 2022 study in *The Lancet Child & Adolescent Health* found that the gender ratio for ADHD was approximately 2:1 in clinical samples — but when community samples were examined, where children were screened regardless of referral, the ratio narrowed significantly. The implication is clear: many girls with ADHD are simply never identified.

We built a diagnostic system around the symptoms of boys and then declared that girls rarely have ADHD. That is not science. That is circular reasoning.

The Consequences of Being Invisible

The consequences of delayed or missed ADHD diagnosis in women are not abstract. They are lived, daily, and cumulative.

Women with undiagnosed ADHD are significantly more likely to develop anxiety and depression. They are more likely to develop eating disorders. They are more likely to struggle in academic and professional settings, not because they lack ability but because the executive function deficits that accompany ADHD make it difficult to organise, prioritise, and sustain attention on tasks that do not intrinsically motivate them. They are more likely to be in abusive relationships, in part because ADHD-related impulsivity and emotional dysregulation can make it harder to recognise and leave harmful situations.

In India, where I grew up, the consequences are compounded by cultural expectations. Girls are expected to be organised, nurturing, and self-sacrificing. A girl who forgets household tasks, loses her textbooks, or cannot sit still is not seen as having a neurodevelopmental condition. She is seen as flawed. The shame is immense and personal, and it follows women into adulthood.

Many women I have spoken to in ADHD support groups in India describe a lifetime of being told they are lazy, careless, or unintelligent. The emotional toll is devastating. "I spent thirty years thinking there was something fundamentally wrong with me," one woman told me. "Not just different. Wrong."

The Hyperfocus Myth and the Masking Problem

One of the reasons ADHD in women is so frequently missed is the phenomenon of hyperfocus — the ability to become intensely absorbed in a task of interest. Women with ADHD can often sustain focus on things they find stimulating, which leads clinicians and family members to conclude that their inattention is selective rather than neurological.

But hyperfocus is not a superpower. It is a dysregulation of attention, not a mastery of it. A woman with ADHD may hyperfocus on a creative project for twelve hours and then be unable to read a single page of a textbook. She may lose an entire afternoon to an internet rabbit hole and then panic about a deadline. The inability to control what captures her attention is precisely the problem.

Masking — the practice of hiding ADHD symptoms by mimicking neurotypical behaviour — is another significant factor. Women are socialised to be attuned to social expectations, and many develop sophisticated strategies for concealing their difficulties. They overcompensate by being obsessively organised, by arriving early, by checking and rechecking their work. The effort of masking is exhausting, and it means that by the time a woman seeks a diagnosis, she may appear to be functioning well enough that her distress is dismissed.

Masking is not coping. It is a full-time job that no one sees and no one pays you for.

The Medication Question

When women with ADHD do receive a diagnosis, they often face scepticism about medication. Stimulant medications — methylphenidate and amphetamine-based drugs — are the first-line treatment for ADHD and are highly effective for a significant proportion of patients. But women report being told that medication is unnecessary, that they should try therapy first, that their ADHD is mild enough to manage without drugs.

This reluctance is gendered. Research suggests that clinicians are more likely to prescribe stimulant medication to boys and men than to girls and women with comparable symptom severity. The reasons are complex: concerns about side effects, about weight loss, about reproductive health — concerns that are rarely raised with male patients.

In India, access to ADHD medication is itself a barrier. Stimulant medications are classified as controlled substances, and many psychiatrists are reluctant to prescribe them. A diagnosis without the possibility of effective treatment can feel like an insult.

Telling a woman she has ADHD and then refusing to treat it is like diagnosing someone with a broken leg and telling them to walk it off.

What Needs to Change

The changes required are both structural and cultural. Diagnostic criteria need to be revised to account for the inattentive presentation that is more common in women. Training programmes for clinicians need to include ADHD in women as a specific topic. Screening tools need to be validated across gender, and clinicians need to be educated about the ways ADHD manifests differently across the lifespan.

In India, where mental health infrastructure is already stretched thin, this represents a significant challenge. But it is not an impossible one. The growing ADHD awareness community in India — largely driven by women sharing their stories on social media — has already shifted the conversation. Diagnosis rates among Indian women are increasing, though they remain far below estimated prevalence.

The women sharing their ADHD stories online are not looking for sympathy. They are looking for the recognition that was denied to them for decades.

Living With the Diagnosis

I will not pretend that a diagnosis at thirty-one felt like a triumph. There was grief — for the years of struggle, for the opportunities lost to executive dysfunction, for the child who was told she was lazy when she needed help. But there was also relief. And there was treatment. Medication did not transform me into a different person. It quieted the noise enough for me to function as the person I already was.

The diagnosis gap is closing, slowly. But every year that a girl grows up without recognition is a year of unnecessary shame, of internalised failure, of missed support. The research was built around boys. It is time to build something better.